-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DoC6eKg9KaI8ymvD608vQ7EeONNayxXZNOFjmsg8p6++ed+nke3esJV5xskTe+TV mvslMNrTwOSqh3sHPpV7TA== /in/edgar/work/0000950133-00-003849/0000950133-00-003849.txt : 20000927 0000950133-00-003849.hdr.sgml : 20000927 ACCESSION NUMBER: 0000950133-00-003849 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000919 ITEM INFORMATION: FILED AS OF DATE: 20000922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: [2836 ] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-26770 FILM NUMBER: 727116 BUSINESS ADDRESS: STREET 1: 8320 GUILFORD RD STREET 2: SUITE C CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 3078543900 MAIL ADDRESS: STREET 1: 8320 GUILFORD ROAD SUITE C CITY: COLUMBIA STATE: MD ZIP: 21046 8-K 1 w40706e8-k.txt 8-K 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 19, 2000 NOVAVAX, INC. -------------- (Exact name of registrant as specified in its charter)
DELAWARE 0-26770 22-2816046 -------- ------- ---------- (State or other jurisdiction (Commission (I.R.S. Employer of incorporation or organization) File No.) Identification No.)
8320 GUILFORD ROAD, COLUMBIA, MD 21046 -------------------------------------- -------- (Address of principal executive offices) (Zip code) (301) 854-3900 ---------------- Registrant's telephone number, including area code NOT APPLICABLE ----------------- (Former name or former address, if changed since last report) 2 ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT On September 19, 2000, the Registrant engaged Ernst & Young LLP to act as the Registrant's independent certified public accountants. Ernst & Young LLP replaces PricewaterhouseCoopers LLP, which firm was dismissed by the Registrant on July 18, 2000. In accordance with S-K Item 304 (a), the Registrant did not consult with Ernst & Young LLP during the Registrant's two most recent fiscal years and any subsequent interim period prior to engaging them regarding matters that were or should have been subject to Statement on Auditing Standard No. 50 or any subject matter of a disagreement or reportable event with the Registrant's former accountant. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVAVAX, INC. Date:September 22, 2000 By: /s/ John A. Spears ------------------------------ John A. Spears, President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----